ANSON D S ET AL: "THE GENE STRUCTURE OF HUMAN ANTI-HAEMOPHILIC FACTOR IX", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 3, no. 5, 1 January 1984 (1984-01-01) , pages 1053-1060, XP000872222, ISSN: 0261-4189 (B1)

CHANG JINLI ET AL: "Changing residue 338 in human factor IX from arginine to alanine causes an increase in catalytic activity", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM, US, vol. 273, no. 20, 15 May 1998 (1998-05-15) , pages 12089-12094, XP002199691, ISSN: 0021-9258 (B1)

DATABASE DATABASE EMBL [Online] 28 January 1986 (1986-01-28), yoshitake s. et al: "Human coagulation factor IX gene, complete cds", XP002774526, retrieved from EBI Database accession no. K02402 (B1)

GIANNELLI F ET AL: "HEMOPHILIA B DATABASE OF POINT MUTATIONS AND SHORT ADDITIONS AND DELETIONS", NUCLEIC ACIDS RESEARCH,, vol. 18, no. 14, 1 January 1990 (1990-01-01), pages 4053-4060, XP002774525, ISSN: 0305-1048, DOI: 10.1093/NAR/18.14.4053 (B1)

JONATHAN D. FINN ET AL: "Abstract 694 - FIX-R338L (FIX Padua) as a Successful Alternative for the Treatment of Canine Severe Hemophilia B", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 114, no. 22, 3 December 2009 (2009-12-03), XP002774527, ISSN: 0006-4971 [retrieved on 2010-10-05] (B1)

KURACHI S ET AL: "ROLE OF INTRON I IN EXPRESSION OF THE HUMAN FACTOR IX GENE", JOURNAL OF BIOLOGICAL CHEMISTRY,, vol. 270, no. 10, 10 March 1995 (1995-03-10), pages 5276-5281, XP002055415, ISSN: 0021-9258, DOI: 10.1074/JBC.270.16.9289 (B1)

YAN JING-BIN ET AL: "Transgenic mice can express mutant human coagulation factor IX with higher level of clotting activity.", BIOCHEMICAL GENETICS OCT 2006, vol. 44, no. 7-8, October 2006 (2006-10), pages 349-360, XP019447249, ISSN: 0006-2928 (B1)

SABATINO DENISE E ET AL: "Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX gene", BLOOD, vol. 104, no. 9, 1 November 2004 (2004-11-01), pages 2767-2774, XP002555908, ISSN: 0006-4971 (B1)

SCHUETTRUMPF JOERG ET AL: "Factor IX variants improve gene therapy efficacy for hemophilia B", BLOOD, vol. 105, no. 6, 15 March 2005 (2005-03-15), pages 2316-2323, XP002555907, ISSN: 0006-4971 (B1)

SIMIONI PAOLO ET AL: "X-linked thrombophilia with a mutant factor IX (factor IX Padua).", THE NEW ENGLAND JOURNAL OF MEDICINE 22 OCT 2009, vol. 361, no. 17, 22 October 2009 (2009-10-22), pages 1671-1675, XP002555909, ISSN: 1533-4406 (B1)

US-A1- 2008 167 219 (B1)

WO-A-99/03496 (B1)

LU H ET AL: "Gene therapy for hemophilia B mediated by recombinant adeno-associated viral vector with hFIXR338A, a high catalytic activity mutation of human coagulation factor IX", SCIENCE IN CHINA. SERIE C: LIFE SCIENCE, GORDON AND BREACH, AMSTERDAM, NL, vol. 44, no. 6, 1 December 2001 (2001-12-01), pages 585-592, XP009114604, ISSN: 1006-9305, DOI: 10.1007/BF02879352 (B1)